Both in Biotechnology
Pelthos Therapeutics vs eXoZymes
Over the past year PTHS returned −72.2% and EXOZ returned −70.6%; their daily moves had a correlation of 0.11.
PTHS −72.2% EXOZ −70.6%Growth of $1, one year, split-adjusted
| Metric | PTHS | EXOZ |
|---|---|---|
| Price | $9.55 | $4.11 |
| Market cap | $37.5M | $38.2M |
| Today | −5.91% | −4.64% |
| 1 month | −54.5% | −25.8% |
| 6 months | −61.8% | −58.9% |
| Year to date | −69.2% | −62.3% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 76.9% | — |
| Net margin | −150.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | — |
| Net cash | -$45.7M | $5.6M |
| Dividend yield | — | — |
| Volatility (60d) | 140.9% | 74.7% |
| Short % of float | 8.6% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).